TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2454788

Group type: EXPERIMENTAL
Intervention: Stimulants (vanillin, phenylethyl alcohol, limonene, menthol, anethol, benzaldehyde, carbon dioxide, mixture of vanillin and carbon dioxide)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Mixture of carbon dioxide and vanillin
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Chemosensory evoked potentials to substances perceived by anosmics (vanillin, phenylethyl alcohol)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Chemosensory evoked potentials to CO2
Number of subjects: 13
Study: 30277507

Group type: EXPERIMENTAL
Intervention: Tailored implementation programme delivered by practice nurses
Number of subjects: 2184

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 2184
Study: 27255289

Group type: EXPERIMENTAL
Intervention: S-1 25 mg/m2 twice daily (cohort 3)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: S-1 20 mg/m2 twice daily (cohort 2)
Number of subjects: 18
Study: 26095389

Group type: EXPERIMENTAL
Intervention: Oesophagectomy (92-OP)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Oesophagectomy plus postoperative chemotherapy (92-POST)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Postoperative chemotherapy (99-POST)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Preoperative chemotherapy (99-PRE)
Number of subjects: 540
Study: 23258223

Group type: EXPERIMENTAL
Intervention: Degarelix 240/80 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Goserelin 3.6 mg + bicalutamide flare protection (G+B)
Number of subjects: 40
Study: 21329822

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.2% cetrimide (CTR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2.5% sodium hypochlorite (NaOCl)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl and 0.2% CTR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7% maleic acid (MA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2% CHX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 17% ethylendiaminetetraacetic (EDTA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7% MA or 17% EDTA followed by 0.2% CTR or 2% CHX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.2% CTR solution alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combinations with 2% CHX or 0.2% CTR as final irrigating solution
Number of subjects: 0
Study: 19863477

Group type: EXPERIMENTAL
Intervention: Albiglutide 15 mg weekly
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Albiglutide 30 mg weekly
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Albiglutide 50 mg biweekly
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Albiglutide 100 mg monthly
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16105862

Group type: EXPERIMENTAL
Intervention: L-Arg infusion (30 g at 0.5 g/min)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (saline alone)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: L-Arg infusion
Number of subjects: 9
Study: 14749239

Group type: EXPERIMENTAL
Intervention: High fruit and vegetable consumption (>= 3 servings/d)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low fruit and vegetable consumption (< 3 servings/d)
Number of subjects: 56
Study: 15590800

Group type: EXPERIMENTAL
Intervention: Regimen A (short-acting morphine tablets and indomethacin rectal suppositories)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Regimen B (long-acting morphine tablets for baseline pain, short-acting morphine tablets for breakthrough pain, and naproxen rectal suppositories)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Superior hypogastric nerve block (SHNB)
Number of subjects: 139
Study: 10673303

Group type: EXPERIMENTAL
Intervention: 10 Fr Teflon Tannenbaum stent (TT)
Number of subjects: 134

Group type: COMPARATOR
Intervention: 10 Fr polyethylene Cotton-Leung stent (CL)
Number of subjects: 134
Study: 11539901

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 81

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 81
Study: 1283188

Group type: EXPERIMENTAL
Intervention: Nilvadipine 16 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3941792

Group type: EXPERIMENTAL
Intervention: gamma‐vinyl GABA therapy, 2 g daily for 2 weeks
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 28544762

Group type: EXPERIMENTAL
Intervention: tooth/tongue gel, tongue cleaner, and mouthwash containing amine fluoride/stannous fluoride and zinc lactate
Number of subjects: 66

Group type: COMPARATOR
Intervention: standard fluoride dentifrice
Number of subjects: 66
Study: 27524385

Group type: EXPERIMENTAL
Intervention: Surgically assisted rapid maxillary expansion (SARME) without pterygomaxillary disjunction (PTMD)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Surgically assisted rapid maxillary expansion (SARME) with pterygomaxillary disjunction (PTMD)
Number of subjects: 15
Study: 24382603

Group type: EXPERIMENTAL
Intervention: Family-based HIV prevention
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Adolescent-only HIV prevention
Number of subjects: 721

Group type: COMPARATOR
Intervention: Adolescent-only health promotion
Number of subjects: 721
Study: 22430344

Group type: EXPERIMENTAL
Intervention: 70% isopropyl alcohol instilled once a week for 2 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no treatment for 2 months)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 70% isopropyl alcohol instilled once a week for 2 months (after crossover)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no treatment for 2 months after crossover)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group 1 during treatment vs nontreatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group 2 during treatment vs nontreatment
Number of subjects: 20
Study: 20686751

Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (0.65 g/kg) administered twice on separate days
Number of subjects: 32
Study: 18792702

Group type: EXPERIMENTAL
Intervention: EBS Multi + Compolute (EC; 3M ESPE)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Syntac + Variolink II low (SV; Ivoclar Vivadent)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both luting systems (EC and SV)
Number of subjects: 31
Study: 15689760

Group type: EXPERIMENTAL
Intervention: Ear plugs
Number of subjects: 201

Group type: COMPARATOR
Intervention: No ear plugs
Number of subjects: 201
Study: 12535286

Group type: EXPERIMENTAL
Intervention: 5% urea cream
Number of subjects: 53

Group type: COMPARATOR
Intervention: Lipid-rich cream
Number of subjects: 53
Study: 10333653

Group type: EXPERIMENTAL
Intervention: Tactile discrimination measured by error rates of either hand
Number of subjects: 0
Study: 8946295

Group type: EXPERIMENTAL
Intervention: Transscleral Nd:YAG cyclophotocoagulation (TYC)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Postoperative hypotony
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Follow-up duration > 6 months
Number of subjects: 479
Study: 1896198

Group type: EXPERIMENTAL
Intervention: ATS injection, oral metronidazole, amoxycillin, diazepam suppositoria plus pyridoxin injection 100 mg on the first day followed by 25 mg orally on the next days
Number of subjects: 31

Group type: COMPARATOR
Intervention: ATS injection, oral metronidazole, amoxycillin, diazepam suppositoria
Number of subjects: 31
Study: 6750396

Group type: EXPERIMENTAL
Intervention: Protriptyline treatment for 2 weeks
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Protriptyline treatment for 6 months
Number of subjects: 5
Study: 30685099

Group type: EXPERIMENTAL
Intervention: LDL-C (per 1 mg/dl increase)
Number of subjects: 9631

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 9631
Study: 28759606

Group type: EXPERIMENTAL
Intervention: Spaced education (Clinical Pearls)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non-reinforced knowledge)
Number of subjects: 0
Study: 25790846

Group type: COMPARATOR
Intervention: Conventional temperature control (group A)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Impedance control (group B)
Number of subjects: 15
Study: 23438224

Group type: EXPERIMENTAL
Intervention: Caffeine (1 mg·kg(‐1) BW)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg·kg(‐1) BW)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg(‐1) BW)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 21953854

Group type: EXPERIMENTAL
Intervention: Venlafaxine hydrochloride 150 mg modified release capsules of Ranbaxy
Number of subjects: 0

Group type: COMPARATOR
Intervention: EFEXOR®-XR 150 mg capsules of Wyeth
Number of subjects: 0
Study: 19052813

Group type: EXPERIMENTAL
Intervention: Escin 5 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Escin 15 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Escin 25 mg
Number of subjects: 72
Study: 17413838

Group type: EXPERIMENTAL
Intervention: Menopause Symptoms Treatment Satisfaction Questionnaire (MS-TSQ)
Number of subjects: 543
Study: 15557412

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins and minerals supplementation (120 mg of ascorbic acid, 30 mg of vitamin E, 6 mg of beta carotene, 100 µg of selenium, and 20 mg of zinc)
Number of subjects: 13017

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13017

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins and minerals supplementation
Number of subjects: 13017

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins and minerals supplementation (men)
Number of subjects: 13017

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins and minerals supplementation (women)
Number of subjects: 13017
Study: 12212667

Group type: EXPERIMENTAL
Intervention: Difficult grip task with right hand
Number of subjects: 0

Group type: COMPARATOR
Intervention: Easy grip task with right hand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Difficult grip task with left hand
Number of subjects: 0

Group type: COMPARATOR
Intervention: Easy grip task with left hand
Number of subjects: 0
Study: 9836544

Group type: EXPERIMENTAL
Intervention: Adjuvant autolymphocyte therapy (ALT) after radical nephrectomy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Observation group (control)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Abdominal CT and chest radiograph
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Abdominal CT alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Follow-up schedule
Number of subjects: 45
Study: 7858555

Group type: EXPERIMENTAL
Intervention: enalapril (mean dose 19mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: doxazosin (mean dose 5.2mg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: enalapril added to doxazosin
Number of subjects: 20

Group type: COMPARATOR
Intervention: doxazosin added to enalapril
Number of subjects: 20
Study: 2551121

Group type: EXPERIMENTAL
Intervention: Vitamin D2 4000 IU daily for 24 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Vitamin D3 4000 IU daily for 24 weeks
Number of subjects: 19
Study: 776328

Group type: EXPERIMENTAL
Intervention: Talampicillin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 47
Study: 7198366

Group type: EXPERIMENTAL
Intervention: Metoprolol 0.22 mg mounted on ophthalmic rods
Number of subjects: 11

Group type: COMPARATOR
Intervention: Timolol eye drops (0.5%)
Number of subjects: 11
Study: 31998164

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 18
Study: 29557078

Group type: EXPERIMENTAL
Intervention: Mazindol 1-3 mg/day
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 27668887

Group type: EXPERIMENTAL
Intervention: Vaccination against HBV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New strategies for predicting seroconversion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subgroup studies in HIV patients with poor immunovirological status
Number of subjects: 0
Study: 23772822

Group type: EXPERIMENTAL
Intervention: Responsive Early Childhood Curriculum (RECC)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: RECC plus explicit social-emotional classroom activities (RECC+)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Business-as-usual control
Number of subjects: 65
Study: 22401315

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 38

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 38
Study: 21143436

Group type: EXPERIMENTAL
Intervention: Targeted referrals to existing community services and health promotion recommendations based on falls risk factors.
Number of subjects: 712

Group type: COMPARATOR
Intervention: Standard care group (control).
Number of subjects: 712
Study: 17369517

Group type: EXPERIMENTAL
Intervention: 15.2-meter walk
Number of subjects: 70

Group type: COMPARATOR
Intervention: 6-minute walk
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 15.2-meter walk (highest quartiles >1.0 m/s)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 6-minute walk (highest quartiles >1.0 m/s)
Number of subjects: 70
Study: 15098334

Group type: EXPERIMENTAL
Intervention: Complex rehabilitation (28 therapeutic sessions over 1 month)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Non-exercising group (control)
Number of subjects: 61
Study: 10699107

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg birth weight at 12-18 hours of age and a second dose 12 hours later)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 384
Study: 9113583

Group type: EXPERIMENTAL
Intervention: 5-second washout of sodium hyaluronate
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 10-second washout of sodium hyaluronate
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 20-second washout of sodium hyaluronate
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Residual sodium hyaluronate concentration
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Kinematic viscosity of sodium hyaluronate
Number of subjects: 107
Study: 8222190

Group type: EXPERIMENTAL
Intervention: FUT‐175 (40 mg/h during cardiopulmonary bypass)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (only heparin)
Number of subjects: 40
Study: 2868753

Group type: EXPERIMENTAL
Intervention: Metipranolol 0.3%
Number of subjects: 10

Group type: COMPARATOR
Intervention: Timolol 0.25%
Number of subjects: 10
Study: 27987441

Group type: EXPERIMENTAL
Intervention: Self-reported data
Number of subjects: 468

Group type: COMPARATOR
Intervention: Administrative data
Number of subjects: 468
Study: 25577300

Group type: EXPERIMENTAL
Intervention: Resveratrol (150 mg capsules, twice daily for three months)
Number of subjects: 60
Study: 24252844

Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg daily
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 21325137

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg daily for 8 weeks)
Number of subjects: 24
Study: 19363221

Group type: EXPERIMENTAL
Intervention: Plerixafor with G-CSF
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo with G-CSF
Number of subjects: 302
Study: 17531579

Group type: EXPERIMENTAL
Intervention: Trandolapril add-on therapy
Number of subjects: 1832
Study: 15361316

Group type: EXPERIMENTAL
Intervention: Blind biopsy alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hysteroscopy with biopsy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasound evaluation including transvaginal ultrasound
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pipelle sampler
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tao brush
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No investigation (low-risk group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biopsy alone (moderate-risk group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hysteroscopy (high-risk group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasound (low-risk group)
Number of subjects: 0
Study: 11568544

Group type: EXPERIMENTAL
Intervention: Dextromethorphan pediatric cough syrup (1 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9458249

Group type: EXPERIMENTAL
Intervention: Tourniquet pressure of 350 mmHg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Tourniquet pressure of 100 mmHg plus systolic blood pressure
Number of subjects: 28
Study: 7696449

Group type: COMPARATOR
Intervention: Pancrease (4 capsules t.d.s.)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Pancrease-HL (1 capsule t.d.s.)
Number of subjects: 13
Study: 3673204

Group type: EXPERIMENTAL
Intervention: Yeast-derived hepatitis B vaccine (YDV)
Number of subjects: 778

Group type: COMPARATOR
Intervention: Commercial plasma-derived vaccine (PDV)
Number of subjects: 778
Study: 30507045

Group type: EXPERIMENTAL
Intervention: Enhanced suctioning of the mouth and oropharynx every 4 hours
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual care (sham suctioning)
Number of subjects: 400
Study: 29019891

Group type: EXPERIMENTAL
Intervention: Novel silicone finger cap
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional film dressing
Number of subjects: 22
Study: 25858203

Group type: EXPERIMENTAL
Intervention: Group therapy for 8 weeks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Group therapy utilizing positive psychology strategies
Number of subjects: 33
Study: 23075433

Group type: EXPERIMENTAL
Intervention: Diode laser therapy adjunct to scaling and root planing (SRP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 35
Study: 19962771

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 12035

Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 12035
Study: 19066612

Group type: EXPERIMENTAL
Intervention: Nurse-led follow-up (n=54)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Standard follow-up (n=55)
Number of subjects: 109
Study: 17959037

Group type: EXPERIMENTAL
Intervention: Combination of celecoxib and octreotide
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 75
Study: 15050264

Group type: EXPERIMENTAL
Intervention: Sharp-edged hydrophobic acrylic IOL (AMO Sensar OptiEdge AR40e)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Round-edged hydrophobic acrylic IOL (AMO Sensar AR40)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Silicone IOL (Pharmacia CeeOn 911A) with polished capsule
Number of subjects: 72

Group type: COMPARATOR
Intervention: Silicone IOL (Pharmacia CeeOn 911A) with unpolished capsule
Number of subjects: 72
Study: 11329494

Group type: EXPERIMENTAL
Intervention: EtOH 0.8 g/kg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: AMP 20 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: AMP 10 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: EtOH 0.8 g/kg and AMP 20 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 10186967

Group type: EXPERIMENTAL
Intervention: PDS membrane with autogenous bone chips
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (without membrane, using periosteum)
Number of subjects: 19
Study: 8052880

Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy (RT), 60 Gy in 30 fractions over 6 weeks
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Accelerated RT, 60 Gy in 30 fractions over 3 weeks
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Conventional RT plus carboplatin 70 mg/m2/d on days 1 to 5 during treatment weeks 1 and 5
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Accelerated RT plus carboplatin 70 mg/m2/d on days 1 to 5 of week 1 only
Number of subjects: 92

Group type: COMPARATOR
Intervention: All study arms
Number of subjects: 92
Study: 2564724

Group type: EXPERIMENTAL
Intervention: Propranolol, 80 mg twice daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dilevalol, 400 mg once daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29619682

Group type: EXPERIMENTAL
Intervention: RP5063
Number of subjects: 175
Study: 28949820

Group type: EXPERIMENTAL
Intervention: Pilates
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PNF
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 25622823

Group type: COMPARATOR
Intervention: UHC
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: UHC + NP
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: UHC + NP + HC
Number of subjects: 495
Study: 23023310

Group type: EXPERIMENTAL
Intervention: Diagnostic medial branch blocks (MBB)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: <50% pain relief after MBB
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Any MBB pain relief cutoff over 50%
Number of subjects: 61
Study: 21765229

Group type: EXPERIMENTAL
Intervention: Supervised exercise program (Group 1)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Supervised exercise program combined with joint and soft tissue mobilization (Group 2)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Home‐based rehabilitation program (Group 3)
Number of subjects: 77
Study: 19958964

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 2868

Group type: COMPARATOR
Intervention: Pravastatin 40 mg
Number of subjects: 2868
Study: 16703602

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 267

Group type: COMPARATOR
Intervention: Community mental health referral
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: PTSD subgroup (comorbid PTSD)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Direct treatment of PTSD
Number of subjects: 267
Study: 15210047

Group type: EXPERIMENTAL
Intervention: 400 micro g of misoprostol vaginally 6 h before dilatation and curettage
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo vaginally 6 h before dilatation and curettage
Number of subjects: 44
Study: 11280890

Group type: EXPERIMENTAL
Intervention: Once a day administration of terazosin (2 mg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Twice a day administration of terazosin (2 mg)
Number of subjects: 42